Share this
global clinical trials: best practices
by Neoteryx on Oct 1, 2019 7:52:01 AM
Multinational clinical trials are essential for the efficient provision of generalizable information to both medical and scientific fields. International trials involving several countries are especially vital for rare diseases. They allow for accelerated patient accruals and increased applicability of the research findings.
International trials, especially when conducted in developing countries, lead to stronger healthcare systems in emerging economies. External funding has the potential of advancing the research capacities of sites in developing nations.
For such a global clinical trial to proceed effectively, you have to foster great relations with all the relevant stakeholders. This includes the sponsors, patients or volunteers, your team, and the policymakers at the national level. The following best practices should be put in place:
Compliance with all essential regulations
You will be faced with numerous schedules and overlaps, leading to an imminent risk of schedule slippage. You should have a clear project plan that outlines and guides all the approval processes.
Seamless information flow and governance
Lack of communication between teams can elicit numerous problems when departments operate independently. You should have a communication plan that allows vendors, sponsors, and other departments to collaborate effectively.
Fast start
Delayed availability of the final protocol can significantly halt patient recruitment. Ensure transparency and actively plan for delays to allow for proper engagement and easy adaptation to change.
Proper budgeting
Clinical trials can be uncertain, turning your budgeting process into a guessing game. If you have efficient change management, the potential risks will be minimal.
Ensuring smooth staff workflows
Inefficient staffing will cause delays, quality bottlenecks, and other delivery shortcomings. You should map and integrate all key processes to clearly define essential data and metrics.
It all boils down to effective business operations
Clinical research is more important all the time, and today's competition for results is strong. You have to optimize your operations for enhanced research sustainability. One way is to embrace microsampling.
Microsampling is an alternative to traditional sampling methods. Your patients will love the new VAMS system because it allows them to save both time and money. Numerous global researchers have embraced this system because of the seamless transportation of samples and smooth dataflow. You can get lots of accurate data from small blood amounts, which can keep patients engaged in the program. This system is a true upgrade for your research.
Share this
- Venipuncture Alternative (109)
- Clinical Trials, Clinical Research (69)
- Mitra® Device (44)
- Research, Remote Research (37)
- Dried Blood Spot, DBS (32)
- Therapeutic Drug Monitoring, TDM (16)
- Decentralized Clinical Trial (DCT) (12)
- Blood Microsampling, Serology (10)
- Infectious Disease, Vaccines, COVID-19 (10)
- Microsampling (9)
- hemaPEN® Device (7)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (6)
- Pharmaceuticals, Drug Development (5)
- Harpera® Tool (4)
- Omics, Multi-Omics (4)
- Skin Microsampling, Microbiopsy (4)
- Antibodies, MAbs (3)
- Biomonitoring, Health, Wellness (3)
- Preclinical Research, Animal Studies (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (4)
- September 2019 (5)
- August 2019 (5)
- July 2019 (4)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (6)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (8)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (7)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (1)